linalyl acetate has been researched along with Hypertension in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hsieh, YS; Kang, P; Kwon, S; Seol, GH; Shin, YK | 1 |
| Hsieh, YS; Kwon, S; Lee, HS; Seol, GH | 1 |
| Han, AY; Hsieh, YS; Kwon, S; Seol, GH; Shin, YK | 1 |
3 other study(ies) available for linalyl acetate and Hypertension
| Article | Year |
|---|---|
Linalyl acetate prevents olmesartan-induced intestinal hypermotility mediated by interference of the sympathetic inhibitory pathway in hypertensive rat.
Topics: Animals; Blood Pressure; Body Weight; Cell Size; Epithelial Cells; Gastrointestinal Motility; Heart Rate; Hypertension; Imidazoles; Male; Monoterpenes; Neural Inhibition; Nitric Oxide; Nitrites; Nitroprusside; Norepinephrine; Rats, Sprague-Dawley; Sympathetic Nervous System; Tetrazoles; Vasodilation | 2018 |
Linalyl acetate prevents hypertension-related ischemic injury.
Topics: Animals; Blood Pressure; Brain Ischemia; Gene Expression Regulation, Enzymologic; Hypertension; Male; Monoterpenes; NADPH Oxidases; Nitric Oxide Synthase Type III; Oxygen; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Vasodilator Agents | 2018 |
Linalyl acetate prevents three related factors of vascular damage in COPD-like and hypertensive rats.
Topics: Animals; Blood Pressure; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Hypertension; L-Lactate Dehydrogenase; Lung; Male; Malondialdehyde; Monoterpenes; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Sprague-Dawley | 2019 |